Cumberland Pharmaceuticals (CPIX) Intangibles (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Intangibles across 17 years of filings, most recently posting $12.8 million for Q1 2026.

• Intangibles for Q1 2026 came in at $12.8 million, down 24.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.8 million (down 24.69% YoY), and the FY2025 annual result was $14.0 million, down 21.95% from the prior year.
• Intangibles came in at $12.8 million for Q1 2026 at Cumberland Pharmaceuticals, down from $14.0 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $34.5 million in Q1 2022 to a low of $12.8 million in Q1 2026.
• The 5-year median for Intangibles is $21.5 million (2024), against an average of $22.9 million.
• Across the five-year window, Intangibles rose 27.7% in 2022 and dropped 28.41% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Intangibles stood at $30.6 million in 2022, then dropped by 26.1% to $22.6 million in 2023, then declined by 20.5% to $18.0 million in 2024, then decreased by 21.95% to $14.0 million in 2025, then slipped by 8.8% to $12.8 million in 2026.
• The last three Intangibles figures came in at $12.8 million (Q1 2026), $14.0 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.